ATE453714T1 - Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen - Google Patents

Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen

Info

Publication number
ATE453714T1
ATE453714T1 AT06011952T AT06011952T ATE453714T1 AT E453714 T1 ATE453714 T1 AT E453714T1 AT 06011952 T AT06011952 T AT 06011952T AT 06011952 T AT06011952 T AT 06011952T AT E453714 T1 ATE453714 T1 AT E453714T1
Authority
AT
Austria
Prior art keywords
therapeutic compositions
diagnostic
antigens
antibodies against
cryptosporidium parvum
Prior art date
Application number
AT06011952T
Other languages
English (en)
Inventor
J Neil Simonsen
Original Assignee
Univ Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Manitoba filed Critical Univ Manitoba
Application granted granted Critical
Publication of ATE453714T1 publication Critical patent/ATE453714T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06011952T 2000-06-15 2001-06-15 Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen ATE453714T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21208300P 2000-06-15 2000-06-15

Publications (1)

Publication Number Publication Date
ATE453714T1 true ATE453714T1 (de) 2010-01-15

Family

ID=22789489

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01944811T ATE407209T1 (de) 2000-06-15 2001-06-15 Cryptosporidium parvum antigene, deren antikörper und deren diagnostische und medische verbindungen
AT06011952T ATE453714T1 (de) 2000-06-15 2001-06-15 Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01944811T ATE407209T1 (de) 2000-06-15 2001-06-15 Cryptosporidium parvum antigene, deren antikörper und deren diagnostische und medische verbindungen

Country Status (8)

Country Link
US (4) US6808900B2 (de)
EP (2) EP1762620B1 (de)
AT (2) ATE407209T1 (de)
AU (1) AU6720601A (de)
CA (1) CA2411949C (de)
DE (2) DE60140972D1 (de)
ES (1) ES2313962T3 (de)
WO (1) WO2001096370A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
CN102698263B (zh) 2005-12-29 2016-07-06 贝林格尔.英格海姆维特梅迪卡有限公司 多价pcv2免疫原性组合物和制备此类组合物的方法
ES2572736T3 (es) 2005-12-29 2016-06-02 Boehringer Ingelheim Vetmedica, Inc. Uso de una composición inmunógena para atenuar síntomas clínicos en cerdos
US20100136060A1 (en) * 2006-11-22 2010-06-03 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
EP2101815A4 (de) 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed Wirksames verfahren zur behandlung von infektionen mit porcinem circovirus und lawsonia intracellularis
AU2007333857B2 (en) 2006-12-15 2014-05-15 Boehringer Ingelheim Animal Health USA Inc. Treatment of pigs with PCV2 antigen
EP1941903A1 (de) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxe und Behandlung von PRDC
EP1958644A1 (de) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Vorbeugung und Behandlung von subklinischer PCVD
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
EP2231182A4 (de) * 2007-12-31 2012-08-22 Boehringer Ingelheim Vetmed Pcv2-orf2-virusähnliche partikel mit fremdaminosäureinsertion
KR20100113582A (ko) 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CN103503841B (zh) * 2013-09-29 2016-01-20 捷胜海洋装备股份有限公司 一种浮球牵引机的牵引结构
ES2778425T3 (es) 2013-10-02 2020-08-10 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024649A1 (en) 1992-05-29 1993-12-09 The Regents Of The University Of California Cryptosporidium polypeptides, nucleic acid, vectors and methods of use
WO1994008012A1 (en) * 1992-10-02 1994-04-14 Research Corporation Technologies, Inc. Methods for increasing secretion of overexpressed proteins
US5591434A (en) 1993-05-26 1997-01-07 The United States Of America As Represented By The Secretary Of Agriculture DNA sequence encoding surface protein of cryptosporidium parvum
CA2263141A1 (en) * 1996-08-23 1998-02-26 North Carolina State University Neutralization-sensitive epitopes of cryptosporidium parvum

Also Published As

Publication number Publication date
WO2001096370A2 (en) 2001-12-20
EP1294889A2 (de) 2003-03-26
EP1762620B1 (de) 2009-12-30
US20050064553A1 (en) 2005-03-24
EP1294889B1 (de) 2008-09-03
US20020034516A1 (en) 2002-03-21
EP1762620A2 (de) 2007-03-14
US20120045464A1 (en) 2012-02-23
ATE407209T1 (de) 2008-09-15
ES2313962T3 (es) 2009-03-16
CA2411949A1 (en) 2001-12-20
EP1762620A3 (de) 2007-04-04
US7288621B2 (en) 2007-10-30
CA2411949C (en) 2012-05-22
AU6720601A (en) 2001-12-24
WO2001096370A3 (en) 2003-01-03
US20080299143A1 (en) 2008-12-04
DE60135655D1 (de) 2008-10-16
WO2001096370A9 (en) 2002-09-19
US6808900B2 (en) 2004-10-26
US7850972B2 (en) 2010-12-14
US8241871B2 (en) 2012-08-14
DE60140972D1 (de) 2010-02-11

Similar Documents

Publication Publication Date Title
ATE453714T1 (de) Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
CY1122505T1 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
HK1080506A1 (en) Fusion proteins of mycobacterium tuberculosis
AU9063801A (en) Methods and compositions for diseases associated with amyloidosis
AU5810201A (en) Immunogenic polypeptides encoded by mage minigenes and uses thereof
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
CY1108387T1 (el) Ανταγωνιστες ανασυνδυασμενης il-18 χρησιμοι στη θεραπεια παθησεων που εμφανιζονται με διαμεσολαβηση της il-18
ATE500843T1 (de) Streptococcus pneumoniae proteine und impfstoffe
DK2054431T3 (da) Konformere af bakterielle adhæsiner
DK1328547T3 (da) Identifikation og modifikation af immundominante epitoper i polypeptider
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
DE60042816D1 (de) T-helferzellen-epitope
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
ATE543906T1 (de) Antigen von streptococcus aus der b-gruppe
DE60043499D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
ATE414154T1 (de) Moraxella (branhamella) catarrhalis antigene
ATE421586T1 (de) Moraxella (branhamella) catarrhalis antigene
ATE382365T1 (de) Thymosin-augmentation bei genetischer immunisierung
WO1999027955A3 (en) Treatment of established chronic infections and cancers
TW200512215A (en) Epitope profiles of SARS coronavirus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties